Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting the risk of diabetic retinopathy in type 2 diabetic patients.
Semeraro F, Parrinello G, Cancarini A, Pasquini L, Zarra E, Cimino A, Cancarini G, Valentini U, Costagliola C. Semeraro F, et al. Among authors: costagliola c. J Diabetes Complications. 2011 Sep-Oct;25(5):292-7. doi: 10.1016/j.jdiacomp.2010.12.002. Epub 2011 Feb 21. J Diabetes Complications. 2011. PMID: 21334925
Diabetic Retinopathy: Vascular and Inflammatory Disease.
Semeraro F, Cancarini A, dell'Omo R, Rezzola S, Romano MR, Costagliola C. Semeraro F, et al. Among authors: costagliola c. J Diabetes Res. 2015;2015:582060. doi: 10.1155/2015/582060. Epub 2015 Jun 7. J Diabetes Res. 2015. PMID: 26137497 Free PMC article. Review.
Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study.
Sasso FC, Pafundi PC, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Galiero R, Acierno C, de Sio C, Adinolfi LE; NO BLIND Study Group. Sasso FC, et al. Among authors: costagliola c. Diabetes Metab Res Rev. 2019 Mar;35(3):e3113. doi: 10.1002/dmrr.3113. Epub 2019 Jan 7. Diabetes Metab Res Rev. 2019. PMID: 30548967
High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study.
Sasso FC, Pafundi PC, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Galiero R, Acierno C, de Sio C, Caturano A, Salvatore T, Adinolfi LE; NO BLIND Study Group. Sasso FC, et al. Among authors: costagliola c. Diabetes Res Clin Pract. 2019 Apr;150:236-244. doi: 10.1016/j.diabres.2019.03.028. Epub 2019 Mar 20. Diabetes Res Clin Pract. 2019. PMID: 30904748
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
Sasso FC, Pafundi PC, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Galiero R, Acierno C, Caturano A, de Sio C, De Nicola L, Salvatore T, Nevola R, Adinolfi LE, Minutolo R; NO BLIND Study Group. Sasso FC, et al. Among authors: costagliola c. Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):923-930. doi: 10.1016/j.numecd.2019.05.065. Epub 2019 Jun 7. Nutr Metab Cardiovasc Dis. 2019. PMID: 31377186
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study.
Pafundi PC, Galiero R, Caturano A, Acierno C, de Sio C, Vetrano E, Nevola R, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Salvatore T, Adinolfi LE, Sasso FC; No Blind Study Group. Pafundi PC, et al. Among authors: costagliola c. Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1806-1812. doi: 10.1016/j.numecd.2020.06.021. Epub 2020 Jun 29. Nutr Metab Cardiovasc Dis. 2020. PMID: 32736957
356 results